About Daniel Haymann
Daniel Haymann
specialises in corporate and commercial law with a focus on investments, venture capital and financing transactions, as well as on regulatory issues in the healthcare and consumer goods sectors, including THC, CBD and other cannabinoids and psychedelic compounds. Daniel is the co-founder and co-chair of the European offshoot of the International Cannabis Bar Association (INCBA Europe).